Idiopathic Pulmonary Fibrosis

Latest News

IPF Top 5 of 2024 | Image Credit: Venngage
Top 5 Most-Read IPF Content of 2024

December 23rd 2024

The top 5 idiopathic pulmonary fibrosis (IPF) articles of 2024 explored topics like the effect of oxygen therapy on health care costs and mortality; delayed diagnoses leading to worse outcomes; new drug trials; the impact of diabetes on pulmonary health; and the growing body of research on macrophages and pulmonary fibrosis.

 Man yawning at work | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com
Patients With ILD Face Higher Burden of Fatigue, Excessive Daytime Sleepiness

December 13th 2024

Highlights from ERS Congress 2024
ICYMI: Highlights From ERS Congress 2024

December 6th 2024

COVID-19 vaccine | Image Credit: M.Rode-Foto - stock.adobe.com
COVID-19 Vaccine Improves Mental Health in Patients With IPF

November 30th 2024

Unmet Needs and Future Treatments of Idiopathic Pulmonary Fibrosis

Learn about the current standard of care for patients with idiopathic pulmonary fibrosis (IPF), including considerations for treatment regimens, disease progression, clinical and economic impact of IPF, and the future of IPF therapies.

Watch the latest AJMC Insights on Idiopathic Pulmonary Fibrosis (IPF).
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo